Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
13F holders, Q4 2022
Institutional positions in Talis Biomedical Corp as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- −2 vs. Q3 2022
- Shares held
- 12.6M
- −30.6K (−0.2%) vs. Q3 2022
- Total value
- $5.60M
- −$2.99M (−34.8%) vs. Q3 2022
- New holders
- 4
- 6 more added
- Sold out
- 6
- 9 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TLIS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $26 |
| Q3 2024 | 2 | $460.4K |
| Q2 2024 | 18 | $6.84M |
| Q1 2024 | 18 | $6.93M |
| Q4 2023 | 18 | $5.93M |
| Q3 2023 | 19 | $4.27M |
| Q2 2023 | 22 | $5.27M |
| Q1 2023 | 22 | $5.76M |
| Q4 2022 | 27 | $5.60M |
| Q3 2022 | 29 | $8.59M |
| Q2 2022 | 35 | $12.1M |
| Q1 2022 | 45 | $23.6M |
| Q4 2021 | 47 | $70.2M |
| Q3 2021 | 38 | $119.2M |
| Q2 2021 | 43 | $184.0M |
| Q1 2021 | 45 | $269.0M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Talis Biomedical Corp; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 1,564 | $0 | 0.00% | −436−21.8% | Reduced |
| Royal Bank of Canada | 123 | $0 | 0.00% | −197−61.6% | Reduced |
| Simplex Trading, LLC | 164 | $0 | 0.00% | +100+156.3% | Added |
| New England Capital Financial Advisors LLC | 10 | $6 | 0.00% | +10 | New |
| Bank of America Corp | 40 | $18 | 0.00% | −123−75.5% | Reduced |
| Wells Fargo & Company | 164 | $73 | 0.00% | +5+3.1% | Added |
| Larson Financial Group LLC | 200 | $89 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 6,743 | $3.04K | 0.00% | +6,717+25,834.6% | Added |
| Tudor Investment Corp Et Al | 10,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 10,760 | $5.00K | 0.00% | +10,760 | New |
| Susquehanna International Group, LLP | 19,409 | $8.64K | 0.00% | +19,409 | New |
| Northern Trust Corp | 27,860 | $12.4K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 32,075 | $14.3K | 0.00% | +2,954+10.1% | Added |
| Renaissance Technologies LLC | 34,900 | $16.0K | 0.00% | +2,700+8.4% | Added |
| State Street Corp | 49,536 | $22.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 59,595 | $26.6K | 0.00% | −19,781−24.9% | Reduced |
| Deutsche Bank AG | 60,120 | $26.8K | 0.00% | 00.0% | Unchanged |
| Mercer Global Advisors Inc | 81,280 | $36.0K | 0.00% | +1,400+1.8% | Added |
| Citadel Advisors LLC | 95,060 | $42.3K | 0.00% | +95,060 | New |
| BlackRock Inc. | 96,959 | $43.2K | 0.00% | −250−0.3% | Reduced |
| Millennium Management LLC | 111,036 | $49.0K | 0.00% | −18,336−14.2% | Reduced |
| Geode Capital Management, LLC | 144,416 | $64.0K | 0.00% | −330−0.2% | Reduced |
| Prelude Capital Management, LLC | 223,934 | $99.8K | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 494,161 | $220.2K | 0.00% | −10,925−2.2% | Reduced |
| ArrowMark Colorado Holdings LLC | 1,159,016 | $515.8K | 0.01% | −37,447−3.1% | Reduced |
| Greenlight Capital Inc | 2,235,783 | $996.5K | 0.07% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 7,624,835 | $3.40M | 0.02% | 00.0% | Unchanged |
| Ergoteles LLC | 0 | $0 | 0.00% | −53,795−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −13,095−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −10,059−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −4,207−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −560−100.0% | Sold out |
| Bogart Wealth, LLC | 0 | $0 | 0.00% | −175−100.0% | Sold out |